Skip to content

Abstract 8830: Prognostic Value of Epicardial Adipose Tissue Volume-to-Density Ratio in Heart Failure with Pulmonary Hypertension: The Modulatory Role of Systemic Inflammation

Nov 2026 · Circulation · 0 citations

Abstract

Background: Epicardial adipose tissue (EAT) volume (EATV) and density (EATD) are emerging imaging biomarkers for cardiovascular risk, yet their combined prognostic value in heart failure (HF) complicated by pulmonary hypertension (PH) remains unclear. PH due to left heart disease (WHO Group 2 PH) affects up to 60-80% of HF patients and confers a worse prognosis. We hypothesized that the ratio of EATV to absolute EATD (EATV/|EATD|), representing fat burden relative to tissue quality, predicts adverse outcomes in this high-risk population, and examined its potential interaction with systemic inflammation. Methods: We retrospectively analyzed 265 inpatients with HF and concomitant PH [defined as pulmonary artery systolic pressure (PASP) ≥35 mmHg on echocardiography] at the Cardiac Department of the First Affiliated Hospital of Dalian Medical University between July 2015 and December 2023. The cohort comprised 101 HFrEF, 52 HFmrEF, and 112 HFpEF patients who underwent cardiac CT. EATV and EATD were quantified using ImageJ (threshold: -190 to -30 HU). The systemic inflammation response index (SIRI) was calculated as neutrophil count (х10 9 /L) х monocyte count (х10 9 /L) / lymphocyte count (х10 9 /L). The primary endpoint was a composite of all-cause mortality and HF hospitalization. Kaplan-Meier curves and log-rank tests compared event-free survival across groups. Cox proportional hazards models were used to assess associations, adjusting for age, sex, BMI, eGFR, LVEF, PASP, BNP, comorbidities and medications. We also tested interaction between the EATV/EATD ratio and SIRI (dichotomized at the median). Results: During median follow-up of 64 months (IQR 35-93), 136 patients (51.3%) experienced the primary endpoint. Patients with events had significantly larger EATV [median (IQR): 73.30 (57.64, 87.86) vs. 64.98 (51.91, 83.49) cm 3 , p<0.05] and higher EATD (-72.50 ± 6.42 vs. -74.42 ± 5.82 HU, p<0.05). Patients were stratified into four groups by median EATV and EATD; the group with high EATV/high EATD had the worst event-free survival and the low/low group had the best (p=0.002) (Figure 1). The continuous EATV/|EATD| ratio was independently associated with the primary endpoint (HR 2.43; 95% CI 1.52-3.89; p=0.002). Notably, this prognostic effect was significant in patients with low SIRI (≤1.15; HR 7.58; 95% CI 2.42-23.71; p=0.003) but not in those with high SIRI (>1.15, HR 1.24; 95% CI 0.51-3.04; p=0.085; p-interaction=0.009) (Figure 2). Conclusion: The EATV/|EATD| ratio, integrating quantitative and qualitative aspects of epicardial fat, independently predicts adverse cardiovascular outcomes in HF patients with concomitant PH. This prognostic value is masked by high systemic inflammation, suggesting that profound systemic inflammatory stress may overwhelm the localized microenvironmental risk signal by EAT remodeling.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.